References from scientific journals

Azithromycin.

Bakheit AH, Al-Hadiya BM, Abd-Elgalil AA. Bakheit AH, et al. Profiles Drug Subst Excip Relat Methodol. 2014;39:1-40. doi: 10.1016/B978-0-12-800173-8.00001-5. Profiles Drug Subst Excip Relat Methodol. 2014. PMID: 24794904 Review.

Azithromycin is an azalide, a subclass of macrolide antibiotics. It is derived from erythromycin, with a methyl-substituted nitrogen atom incorporated into the lactone ring, thus making the lactone ring 15-membered. ...It binds to the 50S subunit of the bacterial ribosome …
Azithromycin is an azalide, a subclass of macrolide antibiotics. It is derived from erythromycin, with a methyl-substituted nitrogen …

Evaluation of 3-day azithromycin or 5-day cefaclor in comparison with 10-day amoxicillin for treatment of tonsillitis in children.

Li P, Jiang G, Shen X. Li P, et al. Can J Physiol Pharmacol. 2019 Oct;97(10):939-944. doi: 10.1139/cjpp-2019-0087. Epub 2019 Jul 31. Can J Physiol Pharmacol. 2019. PMID: 31365280 Clinical Trial.

To evaluate the clinical efficacy of azithromycin, cefaclor, and amoxicillin in treatment of pediatric tonsillitis, a total of 256 children with Group A beta-hemolytic streptococcus (GAS) tonsillitis were randomly divided into 3 groups. ...Treatment-stimulated adverse even …
To evaluate the clinical efficacy of azithromycin, cefaclor, and amoxicillin in treatment of pediatric tonsillitis, a total of 256 ch …

Azithromycin for the treatment of gastroparesis.

Potter TG, Snider KR. Potter TG, et al. Ann Pharmacother. 2013 Mar;47(3):411-5. doi: 10.1345/aph.1R541. Epub 2013 Feb 27. Ann Pharmacother. 2013. PMID: 23447477 Review.

OBJECTIVE: To evaluate the use of azithromycin for the treatment of gastroparesis. DATA SOURCES: Literature was accessed through PubMed/MEDLINE and Web of Science (both 1966-October 2012) using the terms gastroparesis, diabetic gastroparesis, and azithromycin. ...Us …
OBJECTIVE: To evaluate the use of azithromycin for the treatment of gastroparesis. DATA SOURCES: Literature was accessed through PubM …

Azithromycin: The First Broad-spectrum Therapeutic.

Firth A, Prathapan P. Firth A, et al. Eur J Med Chem. 2020 Dec 1;207:112739. doi: 10.1016/j.ejmech.2020.112739. Epub 2020 Aug 19. Eur J Med Chem. 2020. PMID: 32871342 Free PMC article. Review.

Azithromycin is one such broad-spectrum therapeutic that is both included in the University of Oxford's RECOVERY and excluded from the World Health Organization's SOLIDARITY trials. Here we review azithromycin's broad antibiotic, antimalarial, a …
Azithromycin is one such broad-spectrum therapeutic that is both included in the University of Oxford's RECOVERY and excluded …

Clinical Pharmacology Perspectives on the Antiviral Activity of Azithromycin and Use in COVID-19.

Damle B, Vourvahis M, Wang E, Leaney J, Corrigan B. Damle B, et al. Clin Pharmacol Ther. 2020 Aug;108(2):201-211. doi: 10.1002/cpt.1857. Epub 2020 May 12. Clin Pharmacol Ther. 2020. PMID: 32302411 Free PMC article. Review.

Azithromycin (AZ) is a broad-spectrum macrolide antibiotic with a long half-life and a large volume of distribution. ...
Azithromycin (AZ) is a broad-spectrum macrolide antibiotic with a long half-life and a large volume of distribution. ...

Use and safety of azithromycin in neonates: a systematic review.

Smith C, Egunsola O, Choonara I, Kotecha S, Jacqz-Aigrain E, Sammons H. Smith C, et al. BMJ Open. 2015 Dec 9;5(12):e008194. doi: 10.1136/bmjopen-2015-008194. BMJ Open. 2015. PMID: 26656010 Free PMC article. Review.

CONCLUSIONS: Azithromycin significantly reduces the risk of BPD in preterm neonates. The relationship between azithromycin and IHPS requires further investigation....
CONCLUSIONS: Azithromycin significantly reduces the risk of BPD in preterm neonates. The relationship between azithromycin and …

Erythromycin, clarithromycin, and azithromycin: are the differences real?

Amsden GW. Amsden GW. Clin Ther. 1996 Jan-Feb;18(1):56-72; discussion 55. doi: 10.1016/s0149-2918(96)80179-2. Clin Ther. 1996. PMID: 8851453 Review.

Erythromycin, clarithromycin, and azithromycin are clinically effective for the treatment of common respiratory and skin/skin-structure infections. Erythromycin and azithromycin are also effective for treatment of nongonococcal urethritis and cervicitis due to Chlam …
Erythromycin, clarithromycin, and azithromycin are clinically effective for the treatment of common respiratory and skin/skin-structu …

Azithromycin in the treatment of patients with exacerbation of chronic obstructive pulmonary disease.

Płusa T. Płusa T. Pol Merkur Lekarski. 2020 Feb 26;48(283):65-68. Pol Merkur Lekarski. 2020. PMID: 32218410 Review.

The beneficial effects of low dose azithromycin on reducing the number of exacerbations in patients with chronic obstructive pulmonary disease (COPD) have been the subject of many clinical studies. ...In contrast, inhibition of viral infections by azithromycin is ca …
The beneficial effects of low dose azithromycin on reducing the number of exacerbations in patients with chronic obstructive pulmonar …

Azithromycin in viral infections.

Oliver ME, Hinks TSC. Oliver ME, et al. Rev Med Virol. 2021 Mar;31(2):e2163. doi: 10.1002/rmv.2163. Epub 2020 Sep 23. Rev Med Virol. 2021. PMID: 32969125 Free PMC article. Review.

Azithromycin (AZM) is a synthetic macrolide antibiotic effective against a broad range of bacterial and mycobacterial infections. ...
Azithromycin (AZM) is a synthetic macrolide antibiotic effective against a broad range of bacterial and mycobacterial infections. ...

Azithromycin administered for acute bronchiolitis may have a protective effect on subsequent wheezing.

Luisi F, Roza CA, Silveira VD, Machado CC, Rosa KMD, Pitrez PM, Jones MH, Stein RT, Leitão LAA, Comaru T, Mocellin M, Pinto LA. Luisi F, et al. J Bras Pneumol. 2020 Mar 2;46(3):e20180376. doi: 10.36416/1806-3756/e20180376. eCollection 2020. J Bras Pneumol. 2020. PMID: 32130359 Free article. Clinical Trial. English, Portuguese.

Recent studies have demonstrated protection for recurrent wheeze and lower respiratory morbidity in infants treated with azithromycin during an acute respiratory wheezing. The aim of the present study was to test the hypothesis that administration of azithromycin du …
Recent studies have demonstrated protection for recurrent wheeze and lower respiratory morbidity in infants treated with azithromycin …